Literature DB >> 2153879

Peripheral neuropathies in patients with chronic obstructive pulmonary disease: a multicenter prevalence study.

D Nowak1, M Brüch, F Arnaud, H Fabel, D Kiessling, D Nolte, A Overlack, M Rolke, W T Ulmer, H Worth.   

Abstract

To investigate the prevalence and type of peripheral neuropathies (PNP) in patients with chronic obstructive pulmonary disease (COPD), we studied lung function and blood gases, clinical signs of PNP, and neurophysiological function in 151 patients with COPD without known risk factors for PNP. Mean (SD) age was 65 (10) years, mean arterial PO2 was 59 (9) mmHg, mean ratio of forced expiratory volume in the first second to vital capacity (FEV1.0/VC) was 42 (12%). Thirty patients (20%) had clinically detectable and 6 (4%) had subclinical PNP of mild degree. Fourteen (9%) of the patients with clinically detectable PNP had symptoms due to PNP. Prevalence of PNP increased with severity of hypoxemia (p less than 0.05) and was more pronounced in the lower than in the upper limbs. Age and the degree of hypoxemia were predictors to differentiate between COPD patients with and without PNP. Although the cause of PNP in COPD patients remains unknown, our observations suggest that chronic hypoxemia may contribute to PNP.

Entities:  

Mesh:

Year:  1990        PMID: 2153879     DOI: 10.1007/BF02719672

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  30 in total

Review 1.  Hypoxia, almitrine, and peripheral neuropathy.

Authors:  P Howard
Journal:  Thorax       Date:  1989-04       Impact factor: 9.139

Review 2.  The electrophysiological diagnosis of peripheral neuropathy. A brief review.

Authors:  J A Jarratt
Journal:  Bull Eur Physiopathol Respir       Date:  1987-08

3.  Peripheral neuropathy in chronic disease of the respiratory tract.

Authors:  O Appenzeller; R D Parks; J MacGee
Journal:  Am J Med       Date:  1968-06       Impact factor: 4.965

4.  Almitrine and peripheral nerve function.

Authors:  G Lerebours; N Moore; J Senant
Journal:  Lancet       Date:  1988-10-01       Impact factor: 79.321

5.  Almitrine and peripheral neuropathy.

Authors:  S M Alani; J A Twomey; M D Peake
Journal:  Lancet       Date:  1985-11-30       Impact factor: 79.321

6.  Peripheral neuropathy in chronic obstructive lung disease.

Authors:  N Moore; G Lerebours; J Senant; G Ozenne; P David; G Nouvet
Journal:  Lancet       Date:  1985-12-07       Impact factor: 79.321

7.  Evidence of motor neuron involvement in chronic respiratory insufficiency.

Authors:  G Valli; S Barbieri; P Sergi; Z Fayoumi; P Berardinelli
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-10       Impact factor: 10.154

8.  Nerve conduction impairment in patients with respiratory insufficiency and severe chronic hypoxemia.

Authors:  M Narayan; R Ferranti
Journal:  Arch Phys Med Rehabil       Date:  1978-04       Impact factor: 3.966

9.  Peripheral nerve function in patients with chronic bronchitis receiving almitrine or placebo.

Authors:  M B Allen; K Prowse
Journal:  Thorax       Date:  1989-04       Impact factor: 9.139

10.  Nerve glucose, fructose, sorbitol, myo-inositol, and fiber degeneration and regeneration in diabetic neuropathy.

Authors:  P J Dyck; B R Zimmerman; T H Vilen; S R Minnerath; J L Karnes; J K Yao; J F Poduslo
Journal:  N Engl J Med       Date:  1988-09-01       Impact factor: 91.245

View more
  6 in total

1.  Is cardiovascular disease a risk factor in the development of axonal polyneuropathy?

Authors:  L L Teunissen; H Franssen; J H J Wokke; Y van der Graaf; W H J P Linssen; J D Banga; D M Laman; N C Notermans
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-05       Impact factor: 10.154

2.  Chronic obstructive pulmonary disease is not a risk factor for polyneuropathy: A prospective controlled study.

Authors:  Nora A Visser; Nicolette C Notermans; Ferdinand Teding van Berkhout; Leonard H van den Berg; Alexander Fje Vrancken
Journal:  Chron Respir Dis       Date:  2016-03-15       Impact factor: 2.444

3.  Correlations between nerve function and tissue oxygenation in diabetic patients: further clues to the aetiology of diabetic neuropathy?

Authors:  M J Young; A Veves; M G Walker; A J Boulton
Journal:  Diabetologia       Date:  1992-12       Impact factor: 10.122

4.  Effects of peripheral neuropathy on exercise capacity and quality of life in patients with chronic obstructive pulmonary diseases.

Authors:  Gaye Ulubay; Sevinc Sarinc Ulasli; Serife Savas Bozbas; Tugce Ozdemirel; Metin Karatas
Journal:  Arch Med Sci       Date:  2012-05-09       Impact factor: 3.318

5.  Association Between Severe Chronic Obstructive Pulmonary Disease and Polyneuropathy.

Authors:  Ahmet Arisoy; Abdullah Yilgor; İbrahim H Uney
Journal:  Med Sci Monit       Date:  2021-11-09

6.  The impact of COPD on polyneuropathy: results from the German COPD cohort COSYCONET.

Authors:  K Kahnert; M Föhrenbach; T Lucke; P Alter; F T Trudzinski; R Bals; J I Lutter; H Timmermann; S Söhler; S Förderreuther; D Nowak; H Watz; B Waschki; J Behr; T Welte; C F Vogelmeier; R A Jörres
Journal:  Respir Res       Date:  2020-01-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.